|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.90 USD | -0.90% |
|
+5.70% | +31.39% |
| Market Cap | 2.61B 2.26B 2.12B 1.94B 3.66B 248B 3.71B 24.78B 9.73B 124B 9.79B 9.58B 413B | P/E 2026 * |
16.2x | P/E 2027 * | -14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.66B 1.44B 1.35B 1.23B 2.33B 158B 2.36B 15.78B 6.19B 78.99B 6.23B 6.1B 263B | EV / Sales 2026 * |
2.2x | EV / Sales 2027 * | 14.3x |
| Free-Float |
98.66% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nurix Therapeutics, Inc.
| 1 day | -0.90% | ||
| 1 week | +5.70% | ||
| Current month | +7.39% | ||
| 1 month | +3.68% | ||
| 3 months | +47.66% | ||
| 6 months | +47.92% | ||
| Current year | +31.39% |
| 1 week | 22.64 |  | 25.49 |
| 1 month | 21.23 | | 25.49 |
| Current year | 14.01 | | 25.49 |
| 1 year | 8.2 | | 25.49 |
| 3 years | 4.22 | | 29.56 |
| 5 years | 4.22 | | 37.42 |
| 10 years | 4.22 | | 52.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arthur Sands
CEO | Chief Executive Officer | 64 | 2014-09-17 |
Hans van Houte
DFI | Director of Finance/CFO | 60 | 2016-02-29 |
Seema Rogers
CTO | Chief Tech/Sci/R&D Officer | - | 2019-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Arthur Sands
BRD | Director/Board Member | 64 | 2014-09-17 |
David Lacey
CHM | Chairman | 73 | 2019-07-31 |
Julia Gregory
CHM | Chairman | 72 | 2024-05-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/4/26 | Sell | Chief Financial Officer | -4,761 | 0.0046% | ||
| 8/4/26 | Sell | Chief Technology Officer | -4,111 | 0.0040% | ||
| 8/3/26 | Fiscal year | Compliance Officer | 28,163 | 0.0272% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.90% | +5.70% | +138.29% | +181.64% | 2.61B | |
| -3.25% | +12.81% | +52.96% | +88.86% | 64.9B | |
| +0.69% | +0.96% | +29.39% | +70.50% | 54.05B | |
| -2.36% | -3.10% | -19.16% | -8.66% | 23.16B | |
| +32.75% | +29.52% | +18.14% | +501.03% | 21.46B | |
| +1.87% | +5.08% | +29.88% | -7.94% | 21.25B | |
| -0.79% | +1.79% | +36.31% | -26.13% | 17.94B | |
| -3.37% | +19.44% | +211.98% | +369.13% | 17.03B | |
| +3.29% | +2.09% | +17.32% | +586.49% | 14.99B | |
| -6.08% | -5.16% | +40.76% | +162.12% | 14.25B | |
| Average | +2.18% | +3.68% | +55.59% | +191.70% | 25.16B | |
| Weighted average by Cap. | +1.60% | +3.67% | +43.98% | +148.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 755M 655M 614M 561M 1.06B 71.95B 1.07B 7.18B 2.82B 35.95B 2.84B 2.77B 120B | 121M 105M 98.13M 89.76M 169M 11.5B 172M 1.15B 451M 5.75B 453M 444M 19.13B |
| Net income | 368M 319M 299M 274M 517M 35.07B 523M 3.5B 1.37B 17.52B 1.38B 1.35B 58.32B | -174M -151M -141M -129M -244M -16.57B -247M -1.65B -649M -8.28B -653M -639M -27.55B |
| Net Debt | -947M -822M -770M -704M -1.33B -90.25B -1.35B -9.01B -3.53B -45.09B -3.56B -3.48B -150B | -885M -768M -719M -658M -1.24B -84.33B -1.26B -8.42B -3.3B -42.14B -3.32B -3.25B -140B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | US$24.93 | -0.78% | 212,355 |
| 26-08-05 | US$25.12 | +1.74% | 1,343,967 |
| 26-08-04 | US$24.69 | +6.33% | 1,191,583 |
| 26-08-03 | US$23.22 | +0.04% | 1,351,762 |
| 26-07-31 | US$23.21 | -1.57% | 761,745 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NRIX Stock
Select your edition
All financial news and data tailored to specific country editions
